UTK writes to Modi criticizing BJP MP’s attempt to endorse tobacco use in India

Mau/ Kalaburagi, Mar 26: Uttar Pradesh Police on Wednesday asked lockdown violators in Mau to do push-ups and squats as a punishment.
In Karnataka's Kalaburagi, police personnel punished the violators of the lockdown.
In his address to the nation on Tuesday, Prime Minister Narendra Modi announced a 21-day lockdown in the entire country effective from midnight to deal with the spread of coronavirus, saying that "social distancing" is the only option to deal with the disease, which spreads rapidly.
According to the Health Ministry, the total number of positive COVID-19 cases in India reached 606, including 43 foreign nationals.

Mangaluru, Jan 24: Deputy Commissioner Sindhu B Rupesh on Friday said that a specialised task force to manage natural disasters would soon be constituted in all talukas of the Dakshina Kannada district, an official statement said here.

She further said in a meeting of the District Disaster Management Authority that during the floods last monsoon there was a shortage of boats to rescue stranded residents from flood-hit areas. Hence, more boats would be procured for the Home Guards and the Fire and Emergency Services.

She also instructed officials to make sure that schools have their own disaster management plans and also advised them to carry emergency materials kit, used during a natural disaster, in their vehicles.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.